ANALISIS KARAKTERISTIK PROFIL LABORATORIUM IBU HAMIL TERINFEKSI COVID-19 DENGAN KEJADIAN KOMORBID DAN LUARAN PERSALINANNYA DI RSUD WALED PERIODE MARET 2020 - DESEMBER 2021
Keywords:
Ibu hamil, COVID-19, laboratorium, persalinanAbstract
Latar Belakang 13,7% ibu hamil lebih rentan terkena infeksi COVID-19 dan dikhawatirkan terjadi komplikasi
yang tidak menguntungkan seperti kelahiran preterm, kelahiran dengan sectio caesarea hingga kematian perinatal.
Nilai laboratorium dapat dijadikan suatu acuan untuk menilai prognosis pasien. Tujuan Mengetahui
karakteristik profil laboratorium ibu hamil terinfeksi COVID-19 dan luaran persalinannya di RSUD Waled
Metode Penelitian ini merupakan penelitian deskriptif analitik dengan studi retrospektif. Data yang digunakan
didapatkan dari rekam medis. Sampel adalah 20 pasien ibu hamil terinfeksi COVID-19 yang melahirkan di RSUD
Waled pada periode Maret 2020 hingga Desember 2021. Hasil Dari 20 pasien ibu hamil terinfeksi
COVID-19, 70% penurunan kadar hemoglobin, 50% penurunan kadar hematokrit, 70% leukositosis, 85% kadar
trombosit dalam batas normal, 55% neutrositosis, 80% kadar eritrosit normal, 95% limfositopenia, 100% monosit
normal, 65% CRP meningkat, 100% d-dimer meningkat, 65% PT dalam batas normal dan 95% aPTT dalam batas
normal. Terdapat 9 pasien dengan kejadian komorbid. Diantaranya berupa preeklamsia berat, hepatitis b,
hemoroid derajat IV, peripartum cardiomyopathy dan congestive heart failure. Pada uji statistik didapatkan pvalue >0,05 dengan demikian tidak terdapat perbedaan yang signifikan pada profil laboratorium ibu hamil
terinfeksi COVID-19 dengan dan tanpa kejadian komorbid. Terdapat 55% menggunakan metode persalinan
secara pervaginam. 3 dari 20 bayi yang dilahirkan mengalami IUFD. 70% bayi lahir dengan berat badan lahir
normal dan 75% bayi mengalami asfiksia ringan. Kesimpulan Tidak terdapat perbedaan profil laboratorium
antara ibu hamil terinfeksi COVID-19 yang disertai komorbid maupun tanpa komorbid.
Kata Kunci: Ibu hamil, COVID-19, laboratorium, persalinan.
ABSTRACT
Background 13.7% of pregnant women are more susceptible to COVID-19 infection and it is feared that there
will be unfavorable complications such as preterm birth, birth by cesarean section to perinatal death. Laboratory
values can be used as a reference to assess the patient's prognosis. Objective To determine the characteristics of
the laboratory profile of pregnant women infected with COVID-19 and their delivery outcomes at the Waled
Hospital Methods This research is a descriptive analytic study with a retrospective study. The data used were
obtained from medical records. The sample was 20 pregnant women infected with COVID-19 who gave birth at
the Waled Hospital in the period March 2020 to December 2021 Results From 20 pregnant women infected with
COVID-19, 70% decreased hemoglobin levels, 50% decreased hematocrit levels, 70% leukocytosis, 85% platelet
levels within normal limits, 55% neutrocytosis, 80% normal erythrocyte levels, 95% lymphocytopenia, 100 %
monocytes were normal, 65% CRP was increased, 100% d-dimer was increased, 65% PT was within normal
limits and 95% aPTT was within normal limits. There were 9 patients with comorbid events. Among them are
severe preeclampsia, hepatitis b, grade IV hemorrhoids, peripartum cardiomyopathy and congestive heart failure.
In the statistical test, the p-value was > 0.05, thus there was no significant difference in the laboratory profile of
pregnant women infected with COVID-19 with and without comorbid events. There are 55% using the vaginal
delivery method. 3 out of 20 babies born have IUFD. Conclusion There is no difference in the laboratory profile
between pregnant women infected with COVID-19 with or without comorbidities.
Keywords: Pregnant women, COVID-19, laboratory, childbirth.
References
Statistic COVID-19 di Indonesia, https://covid19.go.id diakses 1 Desember 2021.
2. Statistic COVID-19 di Kabupaten Cirebon, http://covid19.cirebonkab.go.id diakses 1
Desember 2021.
3. Azis, et al. REKOMENDASI PENANGANAN INFEKSI VIRUS CORONA (COVID-19)
PADA MATERNAL (HAMIL, BERSALIN DAN NIFAS). 2020
4. Chen H, Guo J, Wang C, Luo F, Yu X, Zhang W, et al. Clinical characteristics and
intrauterine vertical transmission potential of COVID-19 infection in nine pregnant
women: a retrospective review of medical records. The Lancet. 2020 Mar;395(10226):809–
15.
5. Rohmah MK, Nurdianto AR. Corona Virus Disease 2019 (COVID-19) pada Wanita Hamil
dan Bayi: Sebuah Tinjauan Literatur. Medica Hospitalia : Journal of Clinical Medicine.
2020 Aug 28;7(1A):329–36.
6. Mohr-Sasson A, Chayo J, Bart Y, Meyer R, Sivan E, Mazaki-Tovi S, et al. Laboratory
characteristics of pregnant compared to non-pregnant women infected with SARS-CoV-2.
Arch Gynecol Obstet. 2020 Sep 1;302(3):629–34.
7. K. Jakaria Been Sayeed S, Mujibur Rahman Md, K. M. Humayon Kabir A, Moniruzzaman
Md, Mahmud R, Abdullah Yusuf M, et al. Clinical, Laboratory Characteristics and
Pregnancy Outcome of COVID-19 Patients Admitted in the Largest COVID Dedicated
Hospital of Bangladesh. American Journal of Internal Medicine. 2021;9(1):11.
8. Yan J, Guo J, Fan C, Juan J, Yu X, Li J, et al. Coronavirus disease 2019 in pregnant women:
a report based on 116 cases. Am J Obstet Gynecol. 2020 Jul 1;223(1):111.e1-111.e14.
9. Parazzini F, Bortolus R, Mauri PA, Favilli A, Gerli S, Ferrazzi E. Delivery in pregnant
women infected with SARS‐CoV‐2: A fast review. International Journal of Gynecology &
Obstetrics. 2020 Jul;150(1):41–6.
10. Qalaba J, Alit Wardana G. Karakteristik pasien kebidanan dengan infeksi COVID-19 di
Ruang Praja RSUD Wangaya Bali periode Mei-Desember 2020. Intisari Sains Medis |
Intisari Sains Medis [Internet]. 2021;12(1):323–8. Available from: http://isainsmedis.id/
11. Nurinasari H, Prabowo NA, Anggraeni A, Wisdayanti S, Sulistyowati S. Profil
Laboratorium Ibu Hamil dengan COVID-19 di Rumah Sakit UNS. SMART MEDICAL
JOURNAL. 2021;4(2):2621–0916.
12. Saimin J, Ridwan S, Salman S, Hermawan W. Clinical Profi le of Pregnant Women with
COVID-19 Hospitalized in Regional Referral Hospital Profi l Ibu Hamil dengan COVID-
19 yang Dirawat di Rumah Sakit Rujukan.
13. Amorita NA, Syahriarti I. Karakteristik Ibu Hamil dengan Covid-19 dan Luaran
Persalinannya di Rumah Sakit Kasih Ibu Surakarta. Jurnal Kesehatan Reproduksi. 2021
Apr 13;8(1):31.Tunas Medika | Jurnal Kedokteran &
Kesehatan
https://jurnal.ugj.ac.id/index.php/tumed/
14. Jiao J. Under the epidemic situation of COVID-19, should special attention to pregnant
women be given? Vol. 92, Journal of Medical Virology. John Wiley and Sons Inc.; 2020.
p. 1371–2.
15. Vakili S, Savardashtaki A, Jamalnia S, Tabrizi R, Nematollahi MH, Jafarinia M, et al.
Laboratory Findings of COVID-19 Infection are Conflicting in Different Age Groups and
Pregnant Women: A Literature Review. Vol. 51, Archives of Medical Research. Elsevier
Inc.; 2020. p. 603–7.
16. Burhan E, Dwi Susanto A, Isbaniah F, Aman Nasution S, Ginanjar E, Wicaksono Pitoyo
C, et al. PEDOMAN TATALAKSANA COVID-19 Edisi 3 TIM EDITOR Perhimpunan
Dokter Paru Indonesia (PDPI) Perhimpunan Dokter Spesialis Kardiovaskular Indonesia
(PERKI) Perhimpunan Dokter Spesialis Penyakit Dalam Indonesia (PAPDI) Perhimpunan
Dokter Anestesiologi dan Terapi Intensif Indonesia (PERDATIN) Ikatan Dokter Anak
Indonesia (IDAI). 2020.
17. Ejaz H, Alsrhani A, Zafar A, Javed H, Junaid K, Abdalla AE, et al. COVID-19 and
comorbidities: Deleterious impact on infected patients. Vol. 13, Journal of Infection and
Public Health. Elsevier Ltd; 2020. p. 1833–9.
18. Zhang C, Chu H, Pei YV, Zhang J. Laboratory Effects of COVID-19 Infection in Pregnant
Women and Their Newborns: A Systematic Review and Meta-Analysis. Front Glob
Womens Health [Internet]. 2021 Apr 13;2:647072. Available from:
https://pubmed.ncbi.nlm.nih.gov/34816200
19. Kusuma AANJ, Aryana MBD, Mahendra INB, Susanto DH. Description of Neutrophil-tolymphocyte Ratio, C-reactive Protein, and Procalcitonin Levels in Pregnancy with COVID-
19 at Sanglah General Hospital Period of April 2020–April 2021. Journal of South Asian
Federation of Obstetrics and Gynaecology [Internet]. 2022 Aug 22;14(4):445–52.
Available from: https://www.jsafog.com/doi/10.5005/jp-journals-10006-2105
20. Vlachodimitropoulou Koumoutsea E, Vivanti AJ, Shehata N, Benachi A, le Gouez A,
Desconclois C, et al. COVID‐19 and acute coagulopathy in pregnancy. Journal of
Thrombosis and Haemostasis. 2020 Jul 26;18(7):1648–52.
21. Abbas AM, Moris MS, Abdo MS, El-Saaid Monib FA, Hashem H, Ashraf Salah M, et al.
Archives of Health Science Review Article Archives of Health Science 1.
22. KEPUTUSAN MENTERI KESEHATAN REPUBLIK INDONESIA NOMOR HK.
01.07/MENKES/214/2019 TENTANG PEDOMAN NASIONAL PELAYANAN
KEDOKTERAN TATA LAKSANA ASFIKSIA
Downloads
Published
Issue
Section
Citation Check
License
Copyright (c) 2026 Ajeng Siti Arifah, Risnandya Primanagara, Deni Wirhana Surjono, Wildan Arismunandar Sutrisno, Amanah Amanah

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.





